Article
Personalized medicine targeting different ARDS phenotypes: The future of pharmacotherapy for ARDS?
Expert review of respiratory medicine - 1 Jan 2023
Blanchard Florian, James Arthur, Assefi Mona, Kapandji Natacha, Constantin Jean-Michel
Abstract excerpt
INTRODUCTION: Acute respiratory distress syndrome (ARDS) still represents a major challenge with high mortality rates and altered quality of life. Many well-designed studies have failed to improve ARDS outcomes. Heterogeneity of etiologies, mechanisms of lung damage, different lung mechanics, and different treatment approaches may explain these failures. At the era of personalized medicine, ARDS phenotyping is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
